1 / 12

What Is The Success Rate Of Car T-Cell Therapy Treatment

CAR T-cell therapy (Chimeric Antigen Receptor T-cell therapy) has shown promising results as a treatment. Especially in patients who have relapsed or are refractory to other treatments. The success rate of CAR T-cell therapy can vary depending on several factors, including the specific type of CAR T-cell therapy used, the patient's overall health, and how advanced the disease is.<br><br>Click here to More Information :- <br>https://www.edhacare.com/treatments/cancer/car-t-cell-therapy

Johnson64
Download Presentation

What Is The Success Rate Of Car T-Cell Therapy Treatment

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. What Is The Success Rate Of Car T-Cell Therapy Treatment ? https://www.edhacare.com/ Cancer Treatment

  2. Table of Contents 1. What is CAR-T Cell Therapy? 5. Success Rate in Hematologic Cancers 2. How Does It Work? 6. Factors Influencing Success Rate 3. Success Of Car T-Cell Therapy 7. Efficacy Of CAR T-Cell Therapies 4. Importance of Success Rate in Cancer Treatment 8. Conclusion https://www.edhacare.com/treatments/cancer/car-t-cell-therapy

  3. What is CAR-T Cell Therapy? A form of immunotherapy that modifies T-cells to attack cancer. Car T-Cell Therapy Is primarily used for blood cancers like leukemia and lymphoma. ● ● How Does It Work? ● T-cells are isolated, engineered, and then returned to the patient's body for the destruction of cancerous cells. https://www.edhacare.com/treatments/cancer/car-t-cell-therapy

  4. Success Of Car T-Cell Therapy CAR T-cell therapy (Chimeric Antigen Receptor T-cell therapy) has shown promising results as a treatment. Especially in patients who have relapsed or are refractory to other treatments. The success rate of CAR T-cell therapy can vary depending on several factors, including the specific type of CAR T-cell therapy used, the patient's overall health, and how advanced the disease is. https://www.edhacare.com/treatments/cancer/car-t-cell-therapy

  5. Importance of Success Rate in Cancer Treatment ● Treatment Effectiveness: Guides selection of the most effective therapies based on cancer type and stage. Patient Prognosis: Helps patients understand their chances of recovery and set realistic expectations. Emotional Impact: Provides hope for positive outcomes and prepares patients for realistic expectations. Resource Allocation: Helps prioritize effective treatments for better healthcare planning and policy. ● ● ● https://www.edhacare.com/treatments/cancer/car-t-cell-therapy

  6. Success Rate in Hematologic Cancers 1. Leukemia Acute Lymphoblastic Leukemia (ALL): ● Children have an 85-90% 5-year survival rate, while adults have lower rates due to complex disease. Chronic Myeloid Leukemia (CML): ● Over 90% 5-year survival rate, thanks to the effectiveness of Tyrosine Kinase Inhibitors (TKIs), making it manageable long-term. https://www.edhacare.com/treatments/cancer/car-t-cell-therapy

  7. 2 . Lymphoma Hodgkin Lymphoma: ● High 5-year survival rate of about 87%, with excellent outcomes, especially in younger patients. Non-Hodgkin Lymphoma (NHL): ● 5-year survival rate ranges from 60-80%, depending on subtype and stage of diagnosis. https://www.edhacare.com/treatments/cancer/car-t-cell-therapy

  8. Factors Influencing Success Rate Pre-treatment disease burden: Patients with less aggressive or smaller disease burden may have better outcomes. Age and overall health: Older patients or those with other comorbidities may experience more complications or side effects. Previous treatments: The success of CAR-T can depend on how many lines of therapy a patient has already undergone and their response to those treatments. ➔ ➔ Tip ➔ Factors influencing CAR T-cell therapy success include cancer type, patient's overall health, age, immune system status, cancer stage, treatment resistance, specific CAR T-cell product used, and potential side effects. https://www.edhacare.com/treatments/cancer/car- t-cell-therapy

  9. Efficacy Of CAR T-Cell Therapies: ● In clinical trials, Abecma showed that approximately 73% of patients with heavily pretreated multiple myeloma achieved a complete or partial response to the therapy. Among these, about 33% achieved a stringent complete response . ● The overall response rate (ORR) was around 73-80% in various clinical settings, with the duration of response varying but lasting several months to years in some cases. https://www.edhacare.com/treatments/cancer/car-t-cell-therapy

  10. https://www.edhacare.com/treatments/cancer/car-t-cell-therapy

  11. Conclusion ● CAR T-cell therapy has shown a high success rate for treating particularly in patients who have failed other treatments. Success rates vary depending on individual factors, but response rates of 70–80% are typical, with complete response rates of 33–67% in clinical trials. CAR-T Therapy is highly successful in treating blood cancers, with remission rates of 80-90% in some cases. A promising future for CAR-T in expanding treatment options for various cancers. ● ● Tip CAR T-cell therapy shows high success rates for blood cancers, particularly leukemia and lymphoma, with remission rates up to 80- 90%. ● https://www.edhacare.com/treatments/cancer/car-t-cell-therapy

  12. https://www.edhacare.com/treatments/cancer/car-t-cell-therapy

More Related